The European Commission’s proposed methodologies for performing EU-wide joint clinical assessments (JCAs) for medicinal products, a key part of the wider health technology assessment Regulation, are open to public scrutiny until 2 April.
The 18-page draft JCA implementing act document sets out a proposed framework for rolling out JCAs under the new...








